Dr. Lei Stanley Qi is an Associate Professor of Bioengineering and Sarafan ChEM-H at Stanford University. He developed the nuclease-dead dCas and a range of CRISPR tools for epigenetic engineering, such as CRISPR interference (CRISPRi), CRISPR activation (CRISPRa), and live cell DNA/RNA imaging. His research
has led to discoveries in the function of the 3D genome and noncoding genetic elements. His lab has
been engineering the human transcriptome to enhance cell therapy. Dr. Qi received a B.S. in Physics
and Math from Tsinghua University, China, in 2005 and a Ph.D. in Bioengineering from the University of
California, Berkeley, where he worked with Prof. Adam Arkin and Dr. Jennifer Doudna. He was a Faculty
Fellow at UCSF before joining Stanford University.
Dr. Lei Stanley Qi is an Associate Professor of Bioengineering and Sarafan ChEM-H at Stanford University. He developed the nuclease-dead dCas and a range of CRISPR tools for epigenetic engineering, such as CRISPR interference (CRISPRi), CRISPR activation (CRISPRa), and live cell DNA/RNA imaging. His research
has led to discoveries in the function of the 3D genome and noncoding genetic elements. His lab has
been engineering the human transcriptome to enhance cell therapy. Dr. Qi received a B.S. in Physics
and Math from Tsinghua University, China, in 2005 and a Ph.D. in Bioengineering from the University of
California, Berkeley, where he worked with Prof. Adam Arkin and Dr. Jennifer Doudna. He was a Faculty
Fellow at UCSF before joining Stanford University.
Dr. Lei Stanley Qi is an Associate Professor of Bioengineering and Sarafan ChEM-H at Stanford University. He developed the nuclease-dead dCas and a range of CRISPR tools for epigenetic engineering, such as CRISPR interference (CRISPRi), CRISPR activation (CRISPRa), and live cell DNA/RNA imaging. His research
has led to discoveries in the function of the 3D genome and noncoding genetic elements. His lab has
been engineering the human transcriptome to enhance cell therapy. Dr. Qi received a B.S. in Physics
and Math from Tsinghua University, China, in 2005 and a Ph.D. in Bioengineering from the University of
California, Berkeley, where he worked with Prof. Adam Arkin and Dr. Jennifer Doudna. He was a Faculty
Fellow at UCSF before joining Stanford University.